Social determinants of health and use of neoadjuvant chemotherapy and germline genetic testing in patients with early stage triple negative breast cancer (TNBC) in the community oncology setting

Abstract excerpt

<title>Abstract</title> <p>Purpose Triple negative breast cancer is a biologically aggressive cancer with limited treatment options. The disease behaves more aggressively in Black women, producing higher mortality rates. Methods With the aim of understanding reasons for this difference in outcomes, a retrospective, observational cohort study was conducted. We sought to correlate social determinants of health wi...

Topics

Open a Topic to create a Post that cites this publication.

• Black or African American
• BRCA1 Protein
• Genetic Predisposition to Disease
• Genetic Testing
• Healthcare Disparities
• Hispanic or Latino
• Mutation
• Triple Negative Breast Neoplasms

Identifiers and source

Literature Corpus work

ce206f08-2438-58eb-847b-879cd2350e5e

DOI

10.21203/rs.3.rs-4366076/v1